Akouos and Blueprint Genetics Announce Resonate Program to Improve Access to Genetic Testing for Auditory Neuropathy
BOSTON, MASSACHUSSETTS – Akouos, Inc. (NASDAQ: AKUS), a precision genetic medicine company dedicated to developing potential gene therapies for individuals living with disabling hearing loss worldwide, and Blueprint Genetics, a Quest Diagnostics company, today announced the Resonate program. The program offers genetic testing to eligible individuals with auditory neuropathy at no cost to participants, their…
Read More
Decibel Therapeutics Announces Exclusive Licensing Agreements for Hearing Loss Gene Therapy Technology
BOSTON, MASSACHUSSETTS – Decibel Therapeutics, a clinical-stage biotechnology company developing novel restorative gene therapeutics to treat hearing loss and balance disorders, has announced exclusive license agreements with the University of Florida (UF) and the University of California, San Francisco (UCSF) for an adeno-associated virus (AAV) gene therapy technology designed to restore hearing to individuals with…
Read More
Akouos Announces Key Leadership Appointments
BOSTON, MASSACHUSSETTS — Akouos, Inc., a precision genetic medicine company dedicated to developing potential gene therapies for individuals living with disabling hearing loss worldwide, announced the appointment of Sachiyo Minegishi as chief financial officer, effective today. In addition, the company announced that Jennifer Wellman has been promoted to chief operating officer, from her prior…
Read More
Akouos Announces Expansion of Executive Team and Board of Directors
BOSTON, MASSACHUSSETTS — Akouos, Inc. (Nasdaq: AKUS), a precision genetic medicine company dedicated to developing potential gene therapies for individuals living with disabling hearing loss worldwide, today announced the appointment of Alan Smith, Ph.D., as chief technology officer. In addition, the company announced that Saira Ramasastry has been appointed to its board of directors as…
Read More
Researchers Identify Commonly Inherited Genetic Variant as Frequent Cause of Hearing Loss in Adults
A common inherited genetic variant is a frequent cause of hearing loss in adults, meaning that many thousands of people are potentially at risk, reveals research published online in the Journal of Medical Genetics. Hearing loss in adults is known to be inherited. But, unlike childhood hearing loss, the genetic causes largely remain a mystery,…
Read More
UVA Researchers Find Essential Key to Hearing Sensitivity Within the Inner Ear
CHARLOTTESVILLE, VIRGINIA — New research from the University of Virginia School of Medicine is helping shed light on the biological architecture that lets us hear – and on a genetic disorder that causes both deafness and blindness. Sihan Li, a graduate student in the lab of Jung-Bum Shin of UVA’s Department of Neuroscience, has made a surprising…
Read More
Otonomy and AGTC Present Preclinical Results for GJB2 Gene Therapy Hearing Loss Program
SAN DIEGO, CALIFORNIA — Otonomy, Inc., a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced preclinical results from the company’s gene therapy collaboration with Applied Genetic Technologies Corporation (AGTC) that support the selection of a product candidate for development as a treatment for gap junction beta-2 (GJB2) deficiency, the most…
Read More
Research Suggests Potential of In-Womb Gene Correction for Some Genetic Hearing Disorders
PORTLAND, OREGON — New research led by hearing scientists at Oregon Health & Science University (OHSU) suggests an avenue to treat and prevent intractable genetic disorders before birth. Researchers at the Oregon Hearing Research Center at OHSU, working with mice, injected a specially designed synthetic molecule into the developing inner ear of fetal mice 12…
Read More
Gene Therapy Expert, Dr. Géraldine Honnet, Appointed as Sensorion’s New Chief Medical Officer
MONTPELLIER, FRANCE — Sensorion, a clinical-stage biotech company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, has announced the appointment of gene therapy expert Géraldine Honnet MD, as Chief Medical Officer. Géraldine Honnet is a medical doctor and joins from Généthon, where she…
Read More
UK Researchers Identify 44 Genes Tied to Age-Related Hearing Loss, Raising Hope for Future Treatment Options
LONDON, UNITED KINGDOM — Researchers from King’s College London, and University College London (UCL), have identified 44 genes linked to age-related hearing loss. The study helps shed light and provide a much clearer understanding of how the condition develops, and also potential treatment options in the future. The study, published in The American Journal of…
Read More